Hematology
Conference Coverage
Oral voxelotor improves hemoglobin in sickle cell disease
AMSTERDAM – The investigational agent may have disease modifying effects, researchers reported.
News
The costs of surviving cancer
Annual out-of-pocket spending is 60% higher for survivors, the CDC reported.
Photo Rounds
Widespread hyperpigmented plaques
Conference Coverage
Gabapentin falls short in treating sickle cell pain
NEW ORLEANS – Gabapentin plus standard therapy produced results similar to those of placebo plus standard therapy.
News from the FDA/CDC
CDC warns against misuse of opioid-prescribing guideline
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing....
From the Journals
Extended half-life clotting factors cut infusions, hike prices
The use of extended half-life clotting factors was able to significantly reduce the number of infusions but the cost went up significantly.
From the Journals
HAVEN 4: Monthly emicizumab shows value
Emicizumab was effective as a monthly treatment for patients with hemophilia A, both with and without inhibitors, according to an ongoing phase 3...
Conference Coverage
Study highlights lack of data on transgender leukemia patients
NEWPORT BEACH, CALIF. – Researchers identified transgender leukemia patients by detecting gender-karyotype mismatches.
Photo Rounds
Rash with hair loss
Commentary
Powerful breast-implant testimony constrained by limited evidence
SILVER SPRING, MD. – Women report personal horror stories of apparent breast-implant complications, but systematically-collected data remain...
Conference Coverage
FDA panel leans toward more robust breast implant surveillance
SILVER SPRING, MD. – Amid concern over two breast implant complications – anaplastic large cell lymphoma and autoimmune symptoms – an FDA panel...